← All trials
NCT02269475
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2014
- Primary completion
- Apr 1, 2015
- Completion date
- Apr 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 1369
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- AstraZenecaLead sponsor
- Yamada ClinicOverall official - principal investigator
- Yokohama clinicOverall official - principal investigator
- Maeta Pediatrics ClinicOverall official - principal investigator
- Shibasaki internal medicine & Pediatrics ClinicOverall official - principal investigator
- Igarashi Children's ClinicOverall official - principal investigator
- Eiju General HospitalOverall official - principal investigator
- Kyouai ClinicOverall official - principal investigator
- Fukuiken Saiseikai HospitalOverall official - principal investigator
- Yoshimura Children's ClinicOverall official - principal investigator
- Taniguchi Pediatrics ClinicOverall official - principal investigator
- Shinohara Pediatrics ClinicOverall official - principal investigator
- Sotobo Children's ClinicOverall official - principal investigator
- Sakiyama Pediatric ClinicOverall official - principal investigator
- Okawa Children & Family ClinicOverall official - principal investigator
- MORIMOTO ENT CLINICOverall official - principal investigator
- Umemoto Pediatric ClinicOverall official - principal investigator
- Matsuda Pediatrics ClinicOverall official - principal investigator
- Aquair Medical StationOverall official - principal investigator
- Momotaro ClinicOverall official - principal investigator
- Sekino HospitalOverall official - principal investigator
- Yoga Allergy ClinicOverall official - principal investigator
- Ogiwara Ent ClinicOverall official - principal investigator
- Social medical corporation IHL ShinagawaEastOne Medical ClinicOverall official - principal investigator
- Shinkoiwa Ekimae Sougou ClinicOverall official - principal investigator
- Yukisada Clinic for internal diseaseOverall official - principal investigator
- Nemoto-geka-seikeigekaOverall official - principal investigator
- Yajima Children's ClinicOverall official - principal investigator
- Midorino ClinicOverall official - principal investigator
- Tenjin Sogo ClinicOverall official - principal investigator
- Kobori Building ClinicOverall official - principal investigator
- Kimura Shiro ClinicOverall official - principal investigator
- Ueda Naika ClinicOverall official - principal investigator
- Iwaya Children's ClinicOverall official - principal investigator
- Ikeda Naika ClinicOverall official - principal investigator
- Kawai Naika ClinicOverall official - principal investigator
- Ryoshukai Kanauchi Medical ClinicOverall official - principal investigator
- Seisyuukai Funato ClinicOverall official - principal investigator
- Sunrise Medical Research, Inc.Overall official - principal investigator
- Junyokai Musashino General ClinicOverall official - principal investigator
- Kanagawa Prefectural Cancer CenterOverall official - principal investigator
- TanabeOverall official - principal investigator
- Yamaguchi Grand Medical CenterOverall official - principal investigator
- Ito HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.